Riverloft Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Riverloft Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$251K	Buy	+1,250	New	+$249K	0.17%	32

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Riverloft Capital Management's TTPH Position: Q4 2015 in Review

Riverloft Capital Management opened a new position in Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015: 1,250 shares worth $251K. The stake represents 0.17% of the portfolio and ranks #32 among its holdings.

105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

Riverloft Capital Management held 1,250 shares of Tetraphase Pharmaceuticals, Inc. worth $251K as of Q4 2015.
Tetraphase Pharmaceuticals, Inc. was a new Riverloft Capital Management position in Q4 2015.
Tetraphase Pharmaceuticals, Inc. made up 0.17% of Riverloft Capital Management's portfolio in Q4 2015, its #32 holding.
105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Riverloft Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.